Return to study ST003238 main page

MB Sample ID: SA353324

Local Sample ID:Serum_CreERT2_216
Subject ID:SU003357
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Gender:Male and female

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU003357
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Gender:Male and female

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
Serum_CreERT2_216SA353324FL041172serumSample source
Serum_CreERT2_216SA353324FL041172Gclc KOGenotype

Collection:

Collection ID:CO003350
Collection Summary:Mice were anesthetized with isoflurane, after which blood was collected via the retro-orbital venous sinus into BD microtainer tubes (BD #365967). Serum was isolated from the blood by centrifuging blood samples at 10000 xg for 5mins. Samples were stored at -80C.
Sample Type:Blood (serum)

Treatment:

Treatment ID:TR003366
Treatment Summary:Gclc WT (Gclc f/f) and whole-body Gclc KO (Gclc f/f Rosa26-CreERT2) were treated with 160 mg/kg i.p. injection of tamoxifen daily for five consecutive days. After approximately 14 days, mice were euthanized and serum was isolated and stored.

Sample Preparation:

Sampleprep ID:SP003364
Sampleprep Summary:For serum samples, 75 µL of chloroform:methanol extraction solvent (v:v=1:2) was added to 20 µL of mouse serum. After sonicating (1400 rpm, 20°C, 5 min), the extracts were cleared by centrifugation (17,000g, 20°C, 10 min), and the lipids in the supernatant were analyzed by LC-MS.

Combined analysis:

Analysis ID AN005303 AN005304
Analysis type MS MS
Chromatography type Reversed phase Reversed phase
Chromatography system Thermo Vanquish Thermo Vanquish
Column Brownlee SPP C18 (75 x 2.1mm, 2.7um) Brownlee SPP C18 (75 x 2.1mm, 2.7um)
MS Type ESI ESI
MS instrument type Orbitrap Orbitrap
MS instrument name Thermo Q Exactive HF hybrid Orbitrap Thermo Q Exactive HF hybrid Orbitrap
Ion Mode POSITIVE NEGATIVE
Units Normalized to the median value of total lipid signals Normalized to the median value of total lipid signals

Chromatography:

Chromatography ID:CH004012
Chromatography Summary:Brownlee SPP C18 column (2.1 mm × 75 mm, 2.7 μm particle size); Solvent A is 100% H2O containing 0.1% formic acid and 1% of 1 M NH4OAc; Solvent B is 1:1 acetonitrile:isopropanol containing 0.1% formic acid and 1% of 1 M NH4OAc
Instrument Name:Thermo Vanquish
Column Name:Brownlee SPP C18 (75 x 2.1mm, 2.7um)
Column Temperature:50
Flow Gradient:0–2 min 35% B, 2–8 min from 35 to 80% B, 8–22 min from 80 to 99% B, 22–36 min 99% B, and 36.1–40 min from 99 to 35% B.
Flow Rate:0.400 mL/min
Solvent A:100% water; 0.1% formic acid; 10mM ammonium acetate
Solvent B:50% acetonitrile/50% isopropanol; 0.1% formic acid; 10mM ammonium acetate
Chromatography Type:Reversed phase

MS:

MS ID:MS005033
Analysis ID:AN005303
Instrument Name:Thermo Q Exactive HF hybrid Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:The scan range was from m/z 250–1500, resolution was 60,000 for MS, and 30,000 for DDMS2 (top 10), and the AGC target was 3E6 for full MS and 1E5 for DDMS2, allowing ions to accumulate for up to 200 ms for MS and 50 ms for MS/MS. For MS/MS, the following settings are used: isolation window width 1.2 m/z with an offset of 0.5 m/z, stepped NCE at 10, 15, and 25 a.u., minimum AGC 5E2, and dynamic exclusion of previously sampled peaks for 8 s.
Ion Mode:POSITIVE
  
MS ID:MS005034
Analysis ID:AN005304
Instrument Name:Thermo Q Exactive HF hybrid Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:The scan range was from m/z 250–1500, resolution was 60,000 for MS, and 30,000 for DDMS2 (top 10), and the AGC target was 3E6 for full MS and 1E5 for DDMS2, allowing ions to accumulate for up to 200 ms for MS and 50 ms for MS/MS. For MS/MS, the following settings are used: isolation window width 1.2 m/z with an offset of 0.5 m/z, stepped NCE at 10, 15, and 25 a.u., minimum AGC 5E2, and dynamic exclusion of previously sampled peaks for 8 s.
Ion Mode:NEGATIVE
  logo